| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.8 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.8 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |